Until recently, the medical management of coronary artery disease consisted of depressing the heart's requirements for oxygen. Little thought was directed towards improving coronary blood flow as it was believed that atherosclerotic lesions were fixed, unchangeable obstructions. Attempts at pharmacological coronary dilatation were, therefore, considered futile. Within the last few years, these concepts have undergone radical revision.t-3 It is now recognized that coronary stenoses are not fixed but are capable of both dilatation and constriction and these changes can have dramatic effects on blood supply to the heart. Drugs that either dilate or prevent constriction of atherosclerotic coronary articles arc, therefore, of value in patients with coronary artery disease. 4,5 However, paradoxically, drugs that dilate distal intramyocardial coronary arterioles may have the opposite effect. Coronary arteriolar dilatation, in the presence of epicardial atherosclerosis, may exacerbate maldistribution of cornnary blood flow and lead to ischaemia. 2'3'6 This confusing picture is best understood by considering the composition of the coronary vascular system.
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The coronary circulation consists of large proximal coronary arteries that branch and ultimately form an intramyocardial network of small arteries and arterioles. 2-4"7 The arterioles become smaller metarterioles and they eventually form the capillary bed. Blood returns via the coronary venous system. There are major functional differences between the large proximal coronary arteries and the smaller downstream arterioles. The proximal coronary arteries are large bore, relatively thin-walled vessels that lie predominantly on the epieardial surface of the heart. The:so vessels serve to conduct blood from the aorta to the intramyocardial network of arterioles. They are transport vessels 2-'t,7 and contribute little to the overall vascular resistance of the coronary system. They possess considerable reserve capacity and even when blood flow is maximal, such as during extreme exertion, they continue to conduct the much increased flow of blood without imposing resistance. It is these vessels which are visualized during coronary angiography, undergo coronary atheroselerosis and are bypassed during coronary artery_ surgery.
Distal, downstream to the epicardial coronary arteries is a system of smaller arteries, arterioles and metarterioles that end in precapillary sphincters. TM These vessels penetrate throughout the myocardium and are responsible for delivery of blood to the cardiac tissue and for appropriate distribution of blood flow within the myocardlum. They are relatively thick-walled, having a thick smooth muscle coat.
At rest, in normal man, blood flow to the left ventricle is about 60 to 80 ml/100 g myocardium/minute. 7 When myocardial oxygen requirements increase, the resistance vessels dilate and permit myocardial flow to increase in proportion to demand. When oxygen requirements decrease, arterioles constrict and limit flow. For example, the subendocardium has a high metabolic rate yet coronary flow is restricted during systole because of a "throttling" effect of myocardial contraction on intramyocardial vessels, s However, during diastole, subendocardial resistance vessels dilate and blood flow to this region is enhanced and transmural flow is distributed equitably. In this way, intramyocardial vascular tone modulates a tight coupling between oxygen requirements and oxygen supply. Factors responsible for regulating arteriolar tone are not known, but adenosine and other products of metabolism such as potassium ions have ready access to the intramyocardial vessels and are thought to have a regulator role. 9'~~ Epicardial coronary arteries, in contrast, do not participate to any marked extent in flow autoregulation. Even at maximum blood flow rates (mammalian hearts are capable of a six-fold increase in coronary flow), the vessels are of sufficient calibre to permit flow without imposing significant resistance. However, it does appear that some variation in tone occurs and regulatory mechanisms exist. Coronary adrenergic alpha receptors ~* and beta I and beta2 receptors .2 have been identified and serotinergic and neuropeptidergic nerve fibres have been found in mammalian epicardial vessels.t3'*4 Also, high bloodflow states are thought to promote the release of vasodilators from the epicardial vascular endothelium, t s,*s In addition, epicardial arteries are passively dilated when arterial pressure is elevated by manoeuvres such as exercise.
Atheroselerosis impairs the function of this perfusion system. Atherosclerosis involves only the epicardial vessels, not downstream resistance arterioles, t7 Now the previously low-resistance epieardial transport arteries take
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Not only does atherosclerosls raise plaques in the ve~el lumen, it also damages the vascular endothelium. 2z The vascular endothelium has a major role in regulating coronary artery t o n e Y ,24 It does so by synthesizing and releasing vasodilator compounds such as prostacyclin and other as yet undefined relaxing factors (endothelium-dependent relaxing factor -EDRF). 23'~5 It also modifies the effect of circulating factors and vasoactive agents released by blood components such as platelets. Its role in regulating vessel tone is thought to be an evolutionary adaptation. If the endothelium is damaged, such as during traumatic injury, substances released by blood coagulation have direct access to underlying vascular smooth muscle and cause vessel constriction. Blood loss is thus limited, If, on the other hand, clotting were to occur in a normal vessel, then the endothelium (intact in this normal vessel) would intercept the vasoconstrictors released in the process. They would not have ready access to the underlying smooth muscle. In addition, the endothelium modifies the effect of many vasoactive substances, converting them from constrictors to dilators. Vessel dilatation would speed blood flow and help wash away the clot and dilute the clotting factors. The endothelium is, therefore, vital to normal functioning of eplcardial vessels.
Coronary atherosclerosls damages the vascular endothelium (in some respects atherosclerosis resembles vessel injury). Damage, injury, and loss of the endothelium increases adherence of blood elements such as platelets, monocytes, maerophages, and mast cells at the site of the injury. 22 These elements release a number of vasoactive substances, most of them potent vasoconstrictors such as serotonin, 26 thromboxane A2, 27 histamine, zs and leukotrienes. 29 The absence of functioning endothelium results in loss of protection of the underlying vascular smooth muscle. This smooth muscle is now directly exposed to circulating vasoconstrictors. Not only is this vascular barrier lost, but synthesis of vasodilators is also halted, Derangement of endothelial function may explain a susceptibility to vasocensl]-iction that is currently believed to be present in typical coronary artery disease (CAD). ts Loss of protective endothelial function following atherosclerosis has recently been demonstrated in man ( Figure  2 ). 3~ Acetylcholine was used as an example of a vaseconstrictor with endothelium-dependent effects. 3~ (It relaxes normal isolated canine rings but if the endothelium is damaged, these rings will contract.) Acetylcholine was infused directly into the coronary arteries of patients with CAD. Little change occurred in the calibre of normal segments of vessels but in atherosclerotic regions, marked epicardial coronary constriction occurred. The point is not that aeetyleholine is a powerful constrictor of diseased coronary arteries (although it obviously is), but that normal regulation of coronary tone is lost following atherosclerosis. Atheroselerosis, dynamic coronary stenoses, and hypercontractility is a combination that renders the patient extremely vulnerable to myocardial ischaemia.
Factors that trigger dynamic changes in coronary tone are not well understood. In experimental animals, a number of naturally occurring substances such as serotonin, 32 prostaglandins, leukotrienesY neuropeptides, 34 and to a lesser degree alpha agonists 3z produce epicardial coronary artery constriction. In man, no specific factors have been identified, although in susceptible patients coronary constriction can be induced with ergonovine, 35 acetylcholine, 3~ histamine, 36 and dopamine. 3~ There is a relationship between circadian rhythm and susceptibility to angina although spontaneous variations in angina threshold can occur at any time of dayfl s Quantitative coronary angiography has demonstrated that epicardial coronary constriction occurs during handgrip stress 39 and bicycle exercise 21 in patients with CAD, Normal segments of vessels are not constricted and may actually dilate. 21 Exerci~-induced constriction of atherosclerotic vessels and dilatation of normal vessels is shown in Figure 3 . Beneficial effects of nitroglycerin are also demonstrated. Presumably, exercise alters neurohumoral tene and damaged coronary arteries respond inappropriately. Coronary constriction during exercise when myocardial oxygen consumption is elevated and flow demands are high is obviously detrimental. The degree that such dynamic constriction contributes to typical exertional angina is not known. Recent reports suggest thai constriction superimposed upon atheroselerotic stenoses is a major factor in the generation of ischaemia, t,:,t8,2~ ,39 In some respects, the stress of surgery resembles exercise stress as similar neurohumoral changes may accompany both situations. Whether or not eoronat 3, constriction contributes to ischaemia during surgery is not known. Preliminary evidence suggests ntyocardial ischaemia does occur during anaesthesia in the absence of marked changes in myocardial oxygen demand, suggesting that oxygen imbalance may arise from a deficit in supply rather than increase in demand. 4~
In the operating room, tone of both the large proximal and small distal coronary vessels can be readily manipulated. Although proximal vessel dilation (and prevention of constriction) is beneficial and would increase flow in the preserlce of coronary stenoses paradoxically, distal resistance vessel dilation may have adverse effects. 2,3
Equitable distribution of flow within the myocardium is dependent upon appropriate arteriolar tone. If resistance vessel dilation is induced in regions remote from the large vessel stenosis, flow may be distributed away from the potentially ischaemic zone. This phenomenon has been termed "coronary steal. ''42 It has been suggested that isoflurane, 43 nitroprusside, *a and dipyridamole 6 are predominantly arteriolar resistance vessel dilators and these drugs have been associated with maldistribution of coronary flow and appearance or worsening of myocardial ischaemia, (The clinical implications of drug-induced coronary arteriolar dilatation remain controversial. 4s)
Of all the drugs active on the coronary vasculature, nitroglycerin has an unsurpassed reputation for safety and effectiveness. No drug has better withstood the test of time. For many years there has been uncertainty concerning the mechanism of nitroglycerin's therapeutic effect. Undoubtedly, peripheral vasodilation with "unloading" of the heart and reduction in ventricular wall tension is an important therapeutic mechanism but in with permi~,sion of the American Heart Association.) nevertheless extremely effective in preventing constriction. 39 Nifedipine, verapamil, or diltiazem produce only slight epicardial coronary dilatation, far less than does nitroglycerin but all are effective in preventing coronary spasm. Prevention of exercise-induced atherosclerotic coronary artery constriction by diltiazem is illustrated in Figure 6 . Calcium antagonists are generally also coronary artedolar dilators -s but surprisingly, these drugs are not associated with the steal phenomenon, maldistribution of coronary blood flow, nor appearance of myocardial ischaemia. Of the calcium antagonists, nisolthpine is perhaps one of the most potent coronary arteriolar dilators in mart. 47 Perioperative drug therapy may cause epicardial coronary constriction. Histamine release is not uncommon during anaesthesia and surgery and has complex effects on the coronary vasculature) 6 In man, H1 receptor stimulation is thought to induce coronary arteriolar dilatation and, in addition, in susceptible patients may simultaneously cause epicardial coronary artery constriction. Such opposite changes in tone can both predispose to ischaemia (this difference in response of the two types of vessels emphasizes their different regulatory mechanisms). Dopamine has recently been shown to constrict epicardial coronary arteries in susceptible patients. 37 The mechanism is unknown but it has been suggested that serotonaddition it is now quite apparent that epicardial coronary dilatation is also a major factor. High resolution computerenhanced coronary angiography in patients with coronary artery disease has conclusively demonstrated that nitroglycerin not only dilates diseased coronary segments, but also prevents coronary constriction. 2~ Figure  3 shows nitroglycerin's effectiveness both in preventing and treating coronary constriction: actual coronary dilatation occurs. Epicardial coronary dilatation is again demonstrated in Figure 4 . Epicardia] coronary artery dilatation is achieved with little effect on distal coronary arterioles; therefore, nitroglycerin is unlikely to cause steal. Nitroglycerin is perhaps the ideal coronary vasodilator.
Nitropmsside, in contrast, dilates both large and small corooal-y vessels, a4 Epicardial coronary arteries are dilated in both dogs and man; however, the magnitude of this effect is probably less than that achieved with nitroglycerin. This effect is shown in Figure 5 . Nitroprusside dilates coronary arterioles and, therefore, may potentially cause steal and induce or worsen myocardial ischaemia. Whether or not such an effect occurs clinically has not yet been conclusively determined. +5
Calcium antagonist drugs, while not being particularly effective as proximal coronary artery dilators per so, are ergie receptor stimulation may be responsible. Phenylephrine is an alpha agonist which is useful m anaesthetized patients. Whether or not it causes epicardial coronary constriction in patients with coronary disease is unknown. In dogs, it produces only minor epieardia] coronary constriction. 32 Alpha agonists are not thought to be major epicardial coronary constrictors in man and alpha blockade has not proven to be an effective treatment for Prinzmeta] angina.
Anaesthetic drugs have very definite effects on the coronary vasculature. Isoflurane has been shown to be a potent coronary arteriolar dilator. 43''~8 The clinical significance of this effect is yet to be determined as isoflurane has both been implicated in the genesis of myocardial ischaemia 49 and has been shown to protect the stressed heart against ischaemia 5~ In the dog, we have shown coronary arteriolar dilatation to be dose-dependent and although 1.5 MAC isoflurane caused a marked increase in coronary blood flow, 0.5 MAC concentrations had little significant vasodilating effect (Figure 7) . Halothanc, 5t enflurane, s2 and nitrous oxide 53 do not alter coronary arteriolar tone. Epicardial coronary arteries in the dog are not dilated by isoflurane (Figure 8 ). 4s However, when isolated canine coronary tings are exposed to constrictors, isoflurane does attenuate contraction. Attenua- tion of coronary ring contraction by isoflurane is shown in Figure 9 . The mechanism appears to be endotheliumdependent as the effect is lost if the vessel endothelium is damaged. 54 Nitrous oxide, in contrast to isoflurane, constricts canine epicardial coronary arteries. The mechanism is unknown, s5 Nitrous oxide-induced coronary artery constriction is shown in Figure I0 . Whether or not a similar effect occurs in humans is also unknown. When caring for patients with CAD, our aims in the past have been to maintain adequate perfusion pressure, slow the heart rate, depress contractility, and unload the ventricle. To this list of aims must now be added the need In also maintain appropriate epieardial coronary artery and intramyocardial arteriolar tone.
